Skip to content

Health

June 25, 2025 Health Subcommittee Chairman Buchanan Opening Statement: Hearing on Harnessing the Power of Digital Health Data

Today, Ways and Means Health Subcommittee Chairman Vern Buchanan (FL-16) delivered the following remarks during a hearing on harnessing the…

Read More (Health Subcommittee Chairman Buchanan Opening Statement: Hearing on Harnessing the Power of Digital Health Data)
June 19, 2025 Chairman Smith Statement on the 2025 Medicare and Social Security Trustees Reports

WASHINGTON, D.C. – Ways and Means Committee Chairman Jason Smith (MO-08) released the following statement on the 2025 Social Security and…

Read More (Chairman Smith Statement on the 2025 Medicare and Social Security Trustees Reports)
June 16, 2025 The One, Big, Beautiful Bill Empowers American Patients with More Affordable Health Care Choices

WASHINGTON, D.C. – Individuals and families will save on health care expenses and have more coverage options that better fit…

Read More (The One, Big, Beautiful Bill Empowers American Patients with More Affordable Health Care Choices)
May 27, 2025 Chairman Smith, Buchanan, Schweikert Statements on the Trump Administration’s Expansion of Medicare Advantage Audits

WASHINGTON, D.C. – Ways and Means Committee Chairman Jason Smith (MO-08), Ways and Means Health Subcommittee Chairman Vern Buchanan (FL-13), and…

Read More (Chairman Smith, Buchanan, Schweikert Statements on the Trump Administration’s Expansion of Medicare Advantage Audits)
April 17, 2025 Ways & Means Members Call for More Coverage of Chronic Disease Treatments under High-Deductible Health Plans

WASHINGTON, D.C. – The Internal Revenue Service (IRS) needs to update and expand the list of services and treatments for chronic…

Read More (Ways & Means Members Call for More Coverage of Chronic Disease Treatments under High-Deductible Health Plans)
April 10, 2025 Four Key Moments: Hearing on the Health of the Biosimilar Market

WASHINGTON, D.C. – Greater use of biosimilar medications offers a proven pathway to expand access to treatments and cut health care…

Read More (Four Key Moments: Hearing on the Health of the Biosimilar Market)